Intensive tDCS for MDD: Feasibility Study

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Study ID
NCT05194267
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • transcranial direct current stimulation (tDCS) — DEVICE
    tDCS alters brain excitability using a weak electric field induced through two electrodes and could potentially improve symptoms of depression

Study Details

This will be a prospective, open-label, single-arm study to determine the safety and feasibility of an intensive treatment of transcranial direct current stimulation (tDCS) for major depressive disorder (MDD). Participants will be age 18-65 with a diagnosis of unipolar MDD. Participants will receive an intensive treatment of tDCS over a 10-day treatment period and complete follow-up assessments at the end of treatment, 1, and 4 weeks post-treatment.

Key Dates

Start date
Feb 2, 2022
Status verified
Jul 2025
Primary completion
Aug 16, 2023
Completion
Aug 16, 2023

Study Design

Enrollment
30 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Active tDCS
    Will be receiving active intensive tDCS treatment

Primary Outcome Measure

Change in Depressive Symptoms Measured by the Patient Health Questionnaire (PHQ-9) [ Time Frame: T0 (baseline), T1 (1 week after end of treatment) and T2 (one month after the end of the treatment) ]

Related Studies